EN
抗体药类似物
Research Grade Sabatolimab
All
  • CatalogTD-HV029026
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsMBG-453,CAS:2252262-24-9
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Sabatolimab


Catalog No. TD-HV029026
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG4-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target T-cell immunoglobulin mucin receptor 3, HAVcr-2, TIMD-3, T-cell membrane protein 3, HAVCR2, Hepatitis A virus cellular receptor 2, CD366, TIMD3, TIM-3, TIM3, T-cell immunoglobulin and mucin domain-containing protein 3
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q8TDQ0
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names MBG-453,CAS:2252262-24-9
Background Sabatolimab (MBG453) is a high-affinity, humanized, IgG4 (S228P) antibody targeting TIM-3, an inhibitory receptor that regulates adaptive and innate immune responses. Sabatolimab is a potential immunosuppression agent that can target TIM-3 on immune and myeloid cells.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HV029026_1.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Sabatolimab.